Chronic pain disproportionately affects women in the UK, with data suggesting 38% of women experience long-term pain compared to 30% of men. As patients struggle with conditions like endometriosis and menopause-related symptoms, many are turning to private medical cannabis clinics for support when conventional NHS treatments fall short.
The Current Landscape
While medical cannabis was legalised in the UK in 2018, access remains restricted. The NHS typically only prescribes cannabis-based medicines for specific, severe conditions such as rare epilepsy, chemotherapy-induced nausea, and multiple sclerosis-related spasticity. Consequently, patients seeking relief for fibromyalgia, anxiety, or endometriosis often look to private clinics like Releaf.
Clinical Evidence and Regulation
It is vital to note that clinical evidence for cannabis in treating women's health conditions remains limited. The National Institute for Health and Care Excellence (NICE) does not currently recommend THC-based products for chronic pain management, advising that more high-quality clinical trials are required.
Private clinics operate under strict eligibility criteria, typically requiring patients to have a confirmed diagnosis and to have exhausted at least two frontline NHS treatments. Patients must also be aware of potential side effects, including dizziness and nausea, and the risk that regular use may increase the likelihood of developing psychosis in susceptible individuals.
Seeking Advice
If you are struggling with chronic pain, the recommended first step is always to consult your GP. While private clinics offer an alternative route, they are a paid service and not a guaranteed solution. Any discussion regarding medical cannabis should be conducted with transparency about your medical history and current medications.
Source: FemaleFirst




